Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Common Stock
PROF | US
6.66
USD-0.13
-1.91%
PROF | US
Loading StockChartView...
About Common Stock
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
05/06/2026
Close
6.66
Open
6.81
High
7.00
Low
6.62
Profound Medical Corp. together with its subsidiaries operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada Germany the United States and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI) robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise flexible and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve which combines real-time MRI and thermometry for the treatment of uterine fibroids palliative pain treatment of bone metastases and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga Canada.
View LessPROF | US
Risk
38.0
Sharpe
0.21
Luna's Score
36/100
Recommendation
Sell
Luna says (PROF | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
32.4%1 month
38.0%3 months
85.3%6 months
72.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.83
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-5.75
Ent. to rev.
20.62
PEG
-
Other Fundamentals
EBITDA
-29.97M
MarketCap
163.69M
MarketCap(USD)
163.69M
Div. yield
-
Op. margin
-350.78
Erngs. growth
-
Rev. growth
39.40
Ret. on equity
-66.00
Short ratio
4.65
Short perc.
2.71
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.85
Range1M
1.57
Range3M
3.09
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.51
Price X volume
717.40K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.75 | 12.67 | Cheaper |
| Ent. to Revenue | 20.62 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 4.83 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 85.29 | 59.59 | Riskier |
| Debt to Equity | - | -14.36 | - |
| Debt to Assets | - | 0.34 | - |
| Market Cap | 163.69M | 13.71B | Emerging |
